Since these compounds, beside AChE inhibitory activity, often exhibit additional pharmacological properties, especially antioxidants, they could be applied in multi-target strategies for combating the onset and progression of Alzheimer’s disease and other neurological conditions. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.